New York, NY (PRWEB) May 17, 2012
Mount Sinai School of Medicine researchers will benefaction multiform turning point studies, together with data on treatment trends in late-stage cancer, a earnest mixed myeloma vaccine, and predictive models of soft hankie sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) assembly Jun 1-5, 2012 in Chicago.
Highlights of Mount Sinai research at ASCO:


